[1]
Simanek R,Panzer S,Lechner K,Pabinger I, Late spontaneous remissions in severe adult autoimmune thrombocytopenia. Annals of hematology. 2007 Oct; [PubMed PMID: 17503045]
[2]
Hell L,Ay C,Posch F,Gebhart J,Koder S,Mackman N,Pabinger I,Thaler J, Low extracellular vesicle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis. Annals of hematology. 2019 Feb; [PubMed PMID: 30467688]
[3]
Jennings I,Kitchen S,Woods TA,Preston FE,Greaves M, Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Thrombosis and haemostasis. 1997 May; [PubMed PMID: 9184405]
[4]
Tripodi A, Laboratory testing for lupus anticoagulants: a review of issues affecting results. Clinical chemistry. 2007 Sep; [PubMed PMID: 17712001]
[5]
Galli M,Luciani D,Bertolini G,Barbui T, Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003 Mar 1 [PubMed PMID: 12393574]
[6]
de Laat HB,Derksen RH,Urbanus RT,Roest M,de Groot PG, beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood. 2004 Dec 1 [PubMed PMID: 15315975]
[7]
Devreese K,Peerlinck K,Hoylaerts MF, Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants. Blood. 2010 Jan 28 [PubMed PMID: 19965629]
[8]
Favaloro EJ,Mohammed S,Curnow J,Pasalic L, Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives. Pathology. 2019 Apr; [PubMed PMID: 30665674]
[9]
Love PE,Santoro SA, Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Annals of internal medicine. 1990 May 1; [PubMed PMID: 2110431]
[10]
Dembitzer FR,Ledford Kraemer MR,Meijer P,Peerschke EI, Lupus anticoagulant testing: performance and practices by north american clinical laboratories. American journal of clinical pathology. 2010 Nov; [PubMed PMID: 20959659]
[11]
Arnout J, Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. Thrombosis and haemostasis. 2001 Jul; [PubMed PMID: 11487046]
[12]
Passam FH,Rahgozar S,Qi M,Raftery MJ,Wong JW,Tanaka K,Ioannou Y,Zhang JY,Gemmell R,Qi JC,Giannakopoulos B,Hughes WE,Hogg PJ,Krilis SA, Beta 2 glycoprotein I is a substrate of thiol oxidoreductases. Blood. 2010 Sep 16 [PubMed PMID: 20847215]
[13]
Bertolaccini ML,Amengual O,Andreoli L,Atsumi T,Chighizola CB,Forastiero R,de Groot P,Lakos G,Lambert M,Meroni P,Ortel TL,Petri M,Rahman A,Roubey R,Sciascia S,Snyder M,Tebo AE,Tincani A,Willis R, 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmunity reviews. 2014 Sep [PubMed PMID: 24824074]
[14]
Jacobsen EM,Barna-Cler L,Taylor JM,Triplett DA,Wisløff F, The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5. Thrombosis and haemostasis. 2000 May [PubMed PMID: 10823266]
[15]
Urbanus RT,Siegerink B,Roest M,Rosendaal FR,de Groot PG,Algra A, Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. The Lancet. Neurology. 2009 Nov; [PubMed PMID: 19783216]
[16]
Pengo V,Tripodi A,Reber G,Rand JH,Ortel TL,Galli M,De Groot PG,Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis., Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Journal of thrombosis and haemostasis : JTH. 2009 Oct [PubMed PMID: 19624461]
[17]
Tripodi A, To mix or not to mix in lupus anticoagulant testing? That is the question. Seminars in thrombosis and hemostasis. 2012 Jun [PubMed PMID: 22618530]
[18]
Bobba RS,Johnson SR,Davis AM, A review of the sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised sapporo criteria add value? The Journal of rheumatology. 2007 Jul [PubMed PMID: 17552042]
[19]
Miyakis S,Lockshin MD,Atsumi T,Branch DW,Brey RL,Cervera R,Derksen RH,DE Groot PG,Koike T,Meroni PL,Reber G,Shoenfeld Y,Tincani A,Vlachoyiannopoulos PG,Krilis SA, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of thrombosis and haemostasis : JTH. 2006 Feb [PubMed PMID: 16420554]
[20]
Arachchillage DR,Efthymiou M,Mackie IJ,Lawrie AS,Machin SJ,Cohen H, Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism. Thrombosis research. 2015 Feb; [PubMed PMID: 25555316]